Which of the following is not an antiglaucoma drug: September 2006
Since the question is from September 2006, perhaps the original options were specific drugs. Common antiglaucoma drugs include beta blockers like timolol, prostaglandin analogs like latanoprost, alpha agonists like apraclonidine, carbonic anhydrase inhibitors like acetazolamide, and miotics like pilocarpine. So, the incorrect option would be a drug not in this category.
If the correct answer is C, then the other options (A, B, D) must be antiglaucoma drugs. Let's assume the options were something like: A. Timolol, B. Latanoprost, C. Dexamethasone, D. Pilocarpine. Dexamethasone is a corticosteroid, which is not an antiglaucoma drug and might even increase IOP in some cases. So, in this case, C would be the correct answer.
Now, I need to structure the explanation according to the user's guidelines. The core concept is about antiglaucoma drugs. The correct answer is C because it's a steroid, not an antiglaucoma agent. The wrong options are actual antiglaucoma drugs. The clinical pearl is to remember that steroids can worsen glaucoma. The correct answer line is C. Dexamethasone.
**Core Concept**
Antiglaucoma drugs reduce intraocular pressure (IOP) via mechanisms like decreasing aqueous humor production or increasing outflow. Key classes include beta-blockers, prostaglandin analogs, alpha agonists, and carbonic anhydrase inhibitors. **Steroids** are not antiglaucoma agents and may exacerbate glaucoma in susceptible individuals.
**Why the Correct Answer is Right**
**Dexamethasone** is a corticosteroid with anti-inflammatory properties but no role in lowering IOP. Chronic use of steroids can paradoxically increase IOP in predisposed patients, worsening glaucoma. It lacks the pharmacological actions (e.g., cAMP modulation, uveoscleral outflow enhancement) characteristic of true antiglaucoma drugs.
**Why Each Wrong Option is Incorrect**
**Option A:** *Timolol* is a beta-blocker that reduces aqueous humor production.
**Option B:** *Latanoprost* is a prostaglandin analog that increases uveoscleral outflow.
**Option D:** *Pilocarpine* is a miotic agent that enhances trabecular meshwork outflow.
**Clinical Pearl / High-Yield Fact**
Remember the mnemonic **"LAP-BAD"**: **L**atanoprost, **A**pacit, **P**ilocarpine, **B**eta-blockers, **A**lpha agonists, **D**orzolamide. These represent major antiglaucoma drug classes. Steroids